放射治疗治疗量与患者结局相关性的系统综述与Meta分析
该系统综述与Meta分析纳入20项研究,比较高治疗量放疗机构(HVRF)与低治疗量机构(LVRF)患者的结局。汇总分析显示HVRF与较低死亡风险相关(汇总HR 0.90;95%CI 0.87-0.94),鼻咽癌(汇总HR 0.74;95%CI 0.62-0.89)和非鼻咽头颈癌(汇总HR 0.80;95%CI 0.75-0.84)证据最强,前列腺癌次之(汇总HR 0.92;95%CI 0.86-0.98)。作者认为对治疗量-结局关联最强的癌种可考虑集中放疗服务,但需明确考虑对服务公平可及性的影响。
要点
- HVRF与较低死亡风险相关(汇总HR 0.90;95%CI 0.87-0.94)。
- 鼻咽癌汇总HR 0.74(95%CI 0.62-0.89),非鼻咽头颈癌汇总HR 0.80(95%CI 0.75-0.84)。
- 前列腺癌汇总HR 0.92(95%CI 0.86-0.98),其余癌种关联证据弱。
核心结论
- 放射治疗治疗量与患者结局的关联在大多数癌种中存在。
- 对治疗量-结局关联最强的癌种可考虑集中放疗服务,但需明确考虑对服务公平可及性的影响。
研究设计与样本
- 系统综述与Meta分析,检索Ovid MEDLINE和Embase,纳入比较HVRF与LVRF根治性放疗患者结局的研究,共20项。
- Meta分析采用随机效应模型,使用绝对效应和风险比(HR)比较患者结局。
- 纳入研究中7项为头颈癌,其余包括宫颈癌4项、前列腺癌4项、膀胱癌3项、肺癌2项、肛管癌2项、食管癌1项、脑肿瘤2项、肝癌1项、胰腺癌1项。
主要发现
- HVRF与LVRF相比死亡机会更低(汇总HR 0.90;95%CI 0.87-0.94)。
- 鼻咽癌汇总HR 0.74(95%CI 0.62-0.89),非鼻咽头颈癌汇总HR 0.80(95%CI 0.75-0.84)。
- 前列腺癌汇总HR 0.92(95%CI 0.86-0.98)。
- 其余癌种显示治疗量-结局关联证据弱。
- 部分被定义为HVRF的中心每年开展的操作极少(每年<5例放疗病例)。
临床怎么用
- 作者认为对治疗量-结局关联最强的癌种可考虑集中放疗服务,但需明确考虑对服务公平可及性的影响。
局限性
- 部分被定义为HVRF的中心每年开展的操作极少(每年<5例放疗病例)。
- 其余癌种显示治疗量-结局关联证据弱。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Evidence of a volume-outcome association in cancer surgery has shaped the centralization of cancer services; however, it is unknown whether a similar association exists for radiation therapy. The objective of this study was to determine the association between radiation therapy treatment volume and patient outcomes. METHODS AND MATERIALS: This systematic review and meta-analysis included studies that compared outcomes of patients who underwent definitive radiation therapy at high-volume radiation therapy facilities (HVRFs) versus low-volume facilities (LVRFs). The systematic review used Ovid MEDLINE and Embase. For the meta-analysis, a random effects model was used. Absolute effects and hazard ratios (HRs) were used to compare patient outcomes. RESULTS: The search identified 20 studies assessing the association between radiation therapy volume and patient outcomes. Seven of the studies looked at head and neck cancers (HNCs). The remaining studies covered cervical (4), prostate (4), bladder (3), lung (2), anal (2), esophageal (1), brain (2), liver (1), and pancreatic cancer (1). The meta-analysis demonstrated that HVRFs were associated with a lower chance of death compared with LVRFs (pooled HR, 0.90; 95% CI, 0.87- 0.94). HNCs had the strongest evidence of a volume-outcome association for both nasopharyngeal cancer (pooled HR, 0.74; 95% CI, 0.62-0.89) and nonnasopharyngeal HNC subsites (pooled HR, 0.80; 95% CI, 0.75-0.84), followed by prostate cancer (pooled HR, 0.92; 95% CI, 0.86-0.98). The remaining cancer types showed weak evidence of an association. The results also demonstrate that some centers defined as HVRFs are undertaking very few procedures per annum (<5 radiation therapy cases per year). CONCLUSIONS: An association between radiation therapy treatment volume and patient outcomes exists for most cancer types. Centralization of radiation therapy services should be considered for cancer types with the strongest volume-outcome association, but the effect on equitable access to services needs to be explicitly considered.
引用
- Kyaw JYA, Rendall A, Gillespie EF, et al. Systematic Review and Meta-analysis of the Association Between Radiation Therapy Treatment Volume and Patient Outcomes. Int J Radiat Oncol Biol Phys. 2023. PMID: 37227363. doi:10.1016/j.ijrobp.2023.02.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。